AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22770575
Drug: Brinzolamide 1%
RxNorm normalized name: BRINZOLAMIDE 1% SUSP,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brinzolamide 1% plus timolol 0.5% suspension
Trial: 22770575
Drug: Dorzolamide 2%
RxNorm normalized name: Brimonidine Tartrate 0.1%, Dorzolamide 2% Ophthalmic drops, solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide 2% plus timolol 0.5% solution
Trial: 17261962
Drug: CPB with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPB with Baxter Duraflo II heparin-coated circuits, high doses of aprotinin, and pre-CPB hemofiltration
Trial: 9553234
Drug: PCA buprenorphine
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA buprenorphine (intravenous)
Trial: 8094940
Drug: Meperidine 50-100
RxNorm normalized name: meperidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 50-100 mg + midazolam 1-3 mg
Trial: 8094940
Drug: Fentanyl 50-100
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl 50-100 micrograms + midazolam 1-3 mg
Trial: 8094940
Drug: Sufentanil 5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 5-10 micrograms + midazolam 1-3 mg
Trial: 8094940
Drug: Alfentanil 150-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 150-300 micrograms + midazolam 1-3 mg
Trial: 8094940
Drug: Meperidine 50-100
RxNorm normalized name: meperidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 50-100 mg + midazolam 1-3 mg (lower gastrointestinal patients)
Trial: 3775255
Drug: Omeprazole, buffered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole, buffered solution, doses of 10-60 mg
Trial: 3775255
Drug: Omeprazole, buffered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole, buffered solution
Trial: 31552510
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - recreational activities twice a week for 16 weeks
Trial: 30554821
Drug: Control: NT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control: NT (no treatment)
Trial: 28606970
Drug: Tight Control
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tight Control (TC; 4 weekly review with therapy escalation if criteria not met)
Trial: 28606970
Drug: Standard Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Care (SC; 12 weekly review)
Trial: 25051297
Drug: Exposure treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure treatment at 08.00 a.m. (high cortisol group)
Trial: 25051297
Drug: Exposure treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure treatment at 06.00 p.m. (low cortisol group)
Trial: 18667099
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour therapy (CBT) plus treatment as usual (TAU)
Trial: 17315156
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy (Group A)
Trial: 17315156
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy (Group B)
Trial: 9673472
Drug: 0.5% betaxolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% betaxolol HCI, twice-daily bilateral topical ocular dosing for one year
Trial: 2454788
Drug: Stimulants (vanillin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulants (vanillin, phenylethyl alcohol, limonene, menthol, anethol, benzaldehyde, carbon dioxide, mixture of vanillin and carbon dioxide)
Trial: 27255289
Drug: S-1 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 25 mg/m2 twice daily (cohort 3)
Trial: 27255289
Drug: S-1 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 20 mg/m2 twice daily (cohort 2)
Trial: 26095389
Drug: Oesophagectomy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oesophagectomy plus postoperative chemotherapy (92-POST)
Trial: 26095389
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy (99-POST)
Trial: 26095389
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy (99-PRE)
Trial: 21788033
Drug: Degarelix 240/80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Degarelix 240/80 mg
Trial: 23258223
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg + bicalutamide flare protection (G+B)
Trial: 21329822
Drug: 0.2% CTR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% CTR solution alone
Trial: 21329822
Drug: Combinations with
RxNorm normalized name: bucetin, combinations with psycholeptics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combinations with 2% CHX or 0.2% CTR as final irrigating solution
Trial: 19592625
Drug: Albiglutide 50
RxNorm normalized name: ALBIGLUTIDE 50MG/0.5ML INJ PEN 0.5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albiglutide 50 mg biweekly
Trial: 19592625
Drug: Albiglutide 100
RxNorm normalized name: albiglutide 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albiglutide 100 mg monthly
Trial: 16105862
Drug: L-Arg infusion
RxNorm normalized name: L-Arg
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-Arg infusion (30 g at 0.5 g/min)
Trial: 16105862
Drug: L-Arg infusion
RxNorm normalized name: L-Arg
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-Arg infusion
Trial: 15590800
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (short-acting morphine tablets and indomethacin rectal suppositories)
Trial: 15590800
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (long-acting morphine tablets for baseline pain, short-acting morphine tablets for breakthrough pain, and naproxen rectal suppositories)
Trial: 3229870
Drug: Nilvadipine 16
RxNorm normalized name: nilvadipine 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nilvadipine 16 mg
Trial: 3941792
Drug: gamma‐vinyl GABA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gamma‐vinyl GABA therapy, 2 g daily for 2 weeks
Trial: 28544762
Drug: tooth/tongue gel,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tooth/tongue gel, tongue cleaner, and mouthwash containing amine fluoride/stannous fluoride and zinc lactate
Trial: 22430344
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment for 2 months)
Trial: 22430344
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment for 2 months after crossover)
Trial: 22430344
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 during treatment vs nontreatment
Trial: 22430344
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 during treatment vs nontreatment
Trial: 20686751
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose of alcohol (0.65 g/kg) administered twice on separate days
Trial: 12535286
Drug: Lipid-rich cream
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-rich cream
Trial: 1896198
Drug: ATS injection,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATS injection, oral metronidazole, amoxycillin, diazepam suppositoria plus pyridoxin injection 100 mg on the first day followed by 25 mg orally on the next days
Trial: 1896198
Drug: ATS injection,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATS injection, oral metronidazole, amoxycillin, diazepam suppositoria
Trial: 6750396
Drug: Protriptyline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protriptyline treatment for 2 weeks
Trial: 6750396
Drug: Protriptyline treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protriptyline treatment for 6 months
Trial: 30685099
Drug: LDL-C (per
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL-C (per 1 mg/dl increase)
Trial: 23438224
Drug: Caffeine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (1 mg·kg(‐1) BW)
Trial: 23438224
Drug: Caffeine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3 mg·kg(‐1) BW)
Trial: 23438224
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg·kg(‐1) BW)
Trial: 21953854
Drug: Venlafaxine hydrochloride
RxNorm normalized name: Venlafaxine Hydrochloride
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine hydrochloride 150 mg modified release capsules of Ranbaxy
Trial: 21953854
Drug: EFEXOR®-XR 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EFEXOR®-XR 150 mg capsules of Wyeth
Trial: 19052813
Drug: Escin 5
RxNorm normalized name: Escin
DrugBank: Escin (DB15907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escin 5 mg
Trial: 19052813
Drug: Escin 15
RxNorm normalized name: Escin
DrugBank: Escin (DB15907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escin 15 mg
Trial: 19052813
Drug: Escin 25
RxNorm normalized name: beta-escin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escin 25 mg
Trial: 17413838
Drug: Menopause Symptoms
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ)
Trial: 15557412
Drug: Antioxidant vitamins
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamins and minerals supplementation (120 mg of ascorbic acid, 30 mg of vitamin E, 6 mg of beta carotene, 100 µg of selenium, and 20 mg of zinc)
Trial: 9836544
Drug: Adjuvant autolymphocyte
RxNorm normalized name: antilymphocyte immunoglobulin
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant autolymphocyte therapy (ALT) after radical nephrectomy
Trial: 7858555
Drug: enalapril (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril (mean dose 19mg/day)
Trial: 7858555
Drug: doxazosin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: doxazosin (mean dose 5.2mg/day)
Trial: 2551121
Drug: Vitamin D2
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin D2 4000 IU daily for 24 weeks
Trial: 2551121
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 4000 IU daily for 24 weeks
Trial: 7198366
Drug: Metoprolol 0.22
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 0.22 mg mounted on ophthalmic rods
Trial: 29557078
Drug: Mazindol 1-3
RxNorm normalized name: mazindol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazindol 1-3 mg/day
Trial: 10699107
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg/kg birth weight at 12-18 hours of age and a second dose 12 hours later)
Trial: 8222190
Drug: FUT‐175 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FUT‐175 (40 mg/h during cardiopulmonary bypass)
Trial: 8222190
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (only heparin)
Trial: 25577300
Drug: Resveratrol (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol (150 mg capsules, twice daily for three months)
Trial: 24252844
Drug: Pioglitazone 45
RxNorm normalized name: pioglitazone 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 45 mg daily
Trial: 21325137
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg daily for 8 weeks)
Trial: 19363221
Drug: Plerixafor with
RxNorm normalized name: Plerixafor
DrugBank: Plerixafor (DB06809)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Plerixafor with G-CSF
Trial: 19363221
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with G-CSF
Trial: 17531579
Drug: Trandolapril add-on
RxNorm normalized name: Trandolapril
DrugBank: Trandolapril (DB00519)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trandolapril add-on therapy
Trial: 11568544
Drug: Dextromethorphan pediatric
RxNorm normalized name: dextromethorphan hydrobromide Oral Solution [Tussin Pediatric]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan pediatric cough syrup (1 mg/kg)
Trial: 7696449
Drug: Pancrease (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancrease (4 capsules t.d.s.)
Trial: 7696449
Drug: Pancrease-HL (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancrease-HL (1 capsule t.d.s.)
Trial: 3673204
Drug: Yeast-derived hepatitis
RxNorm normalized name: YEAST CELL,LIVE DERIVATIVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yeast-derived hepatitis B vaccine (YDV)
Trial: 3673204
Drug: Commercial plasma-derived
RxNorm normalized name: Haptoglobulin 1/1 (Plasma Derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial plasma-derived vaccine (PDV)
Trial: 25858203
Drug: Group therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group therapy for 8 weeks
Trial: 25858203
Drug: Group therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group therapy utilizing positive psychology strategies
Trial: 23075433
Drug: Diode laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diode laser therapy adjunct to scaling and root planing (SRP)
Trial: 17959037
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of celecoxib and octreotide
Trial: 15050264
Drug: Silicone IOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone IOL (Pharmacia CeeOn 911A) with polished capsule
Trial: 15050264
Drug: Silicone IOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone IOL (Pharmacia CeeOn 911A) with unpolished capsule
Trial: 11329494
Drug: EtOH 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EtOH 0.8 g/kg
Trial: 11329494
Drug: AMP 20
RxNorm normalized name: ROPIVACAINE HCL 1% INJ AMP 20ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMP 20 mg
Trial: 11329494
Drug: AMP 10
RxNorm normalized name: ROPIVACAINE HCL 0.2% INJ AMP 10ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMP 10 mg
Trial: 11329494
Drug: EtOH 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EtOH 0.8 g/kg and AMP 20 mg
Trial: 8052880
Drug: Conventional RT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional RT plus carboplatin 70 mg/m2/d on days 1 to 5 during treatment weeks 1 and 5
Trial: 8052880
Drug: Accelerated RT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated RT plus carboplatin 70 mg/m2/d on days 1 to 5 of week 1 only
Trial: 2564724
Drug: Propranolol, 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, 80 mg twice daily
Trial: 2564724
Drug: Dilevalol, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol, 400 mg once daily
Trial: 16703602
Drug: Direct treatment
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct treatment of PTSD
Trial: 15210047
Drug: 400 micro
RxNorm normalized name: EM 2400 Micro Volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 micro g of misoprostol vaginally 6 h before dilatation and curettage
Trial: 11280890
Drug: Once a
RxNorm normalized name: Once A Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once a day administration of terazosin (2 mg)
Trial: 11280890
Drug: Twice a
RxNorm normalized name: Pataday Twice A Day Relief
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice a day administration of terazosin (2 mg)
Trial: 9248765
Drug: Oestradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oestradiol valerate (4 mg)
Trial: 9248765
Drug: Medroxyprogesterone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone (40 mg)
Trial: 17126768
Drug: Lactobacillus fermentum
RxNorm normalized name: Lactobacillus Fermentum
DrugBank: Lactobacillus fermentum (DB16542)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus fermentum 2 capsules twice daily (2 x 10^9 CFU per capsule) for 10 weeks
Trial: 9850033
Drug: Lenograstim 2
RxNorm normalized name: lenograstim 263 MCG/mL Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenograstim 2 microg/kg daily
Trial: 9850033
Drug: Lenograstim 5
RxNorm normalized name: LENOGRASTIM
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenograstim 5 microg/kg daily
Trial: 7826820
Drug: Nebivolol with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol with L-NMMA infusion
Trial: 3400680
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose regimen: 5 g mezlocillin plus 2 g cefoperazone intravenously every four hours
Trial: 3400680
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose regimen: 3 g mezlocillin plus 1 g cefoperazone intravenously every four hours
Trial: 3400680
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose regimen
Trial: 28844431
Drug: CC (usual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC (usual community care)
Trial: 25769911
Drug: BI 655066
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 655066 (any dose)
Trial: 12751880
Drug: School-based preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based preventive intervention (Botvin, G. J. 1996, 2000)
Trial: 8447207
Drug: Glucose solution
RxNorm normalized name: TrueControl Glucose Solution Level 0
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose solution before surgery and Ringer‐acetate during surgery
Trial: 20628312
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of hypertonic saline-epinephrine (HSE) solution (1 mL) 1 to 2-cm oral to the papilla
Trial: 20628312
Drug: No injection
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injection (noninjection group)
Trial: 17938425
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m2 on day 1 plus gemcitabine 1 gm/m2 on days 1 and 8 (arm A)
Trial: 17938425
Drug: Carboplatin at
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin at AUC of 6 mg on day 1 plus gemcitabine 1 gm/m2 on days 1 and 8 (arm B)
Trial: 17002741
Drug: Post-operative oral
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative oral care including tooth brushing, denture cleaning, and tongue cleaning
Trial: 17002741
Drug: Post-operative oral
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative oral care
Trial: 1425524
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet supplemented with 76 mumol (5 mg) Zn/kg diet
Trial: 1425524
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet supplemented with 153 mumol (10 mg) Zn/kg diet
Trial: 30900659
Drug: Xylitol chewing
RxNorm normalized name: xylitol Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylitol chewing gum (1.1 g each, 2 pieces daily for 14 days)
Trial: 30900659
Drug: Sorbitol chewing
RxNorm normalized name: Sorbitol
DrugBank: Sorbitol (DB01638)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sorbitol chewing gum (1.1 g each, 2 pieces daily for 14 days)
Trial: 18691988
Drug: aranidipine 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aranidipine 5 mg
Trial: 18691988
Drug: aranidipine 10
RxNorm normalized name: lercanidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aranidipine 10 mg
Trial: 18691988
Drug: aranidipine 20
RxNorm normalized name: lercanidipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aranidipine 20 mg
Trial: 18691988
Drug: aranidipine 10
RxNorm normalized name: lercanidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aranidipine 10 mg (multiple doses)
Trial: 18691988
Drug: M-1 metabolite
RxNorm normalized name: factor VIII
DrugBank: Beroctocog alfa (DB14473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M-1 metabolite (aranidipine 10 mg)
Trial: 18691988
Drug: M-1 metabolite
RxNorm normalized name: factor VIII
DrugBank: Beroctocog alfa (DB14473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M-1 metabolite (aranidipine 5 mg)
Trial: 18691988
Drug: M-1 metabolite
RxNorm normalized name: factor VIII
DrugBank: Beroctocog alfa (DB14473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M-1 metabolite (aranidipine 20 mg)
Trial: 15673502
Drug: Newer treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newer treatment strategies